Group 1 - The stock of Brain Dynamics Aurora-B (06681) surged over 14%, reaching HKD 8.5 with a trading volume of HKD 311 million [1] - The Minister of Industry and Information Technology emphasized the need to cultivate emerging industries and accelerate the development of new pillar industries, including human-machine interfaces and quantum information [1] - The National Medical Products Administration approved the first medical device standard for brain-machine interface technology, which will be implemented on January 1, 2026, laying a foundation for the high-quality development of the industry [1] Group 2 - Brain Dynamics' core product is a brain function information management platform, recognized as China's first regulatory-approved digital therapy for cognitive disorders [2] - The company combines brain science with artificial intelligence, offering unique technological advantages such as virtual human technology and AI [2] - The core product is included in the provincial medical insurance reimbursement list across 30 provinces in China, and the company has established cognitive centers in over 120 hospitals, including several certified as "National Medical Centers" [2]
港股异动 | 脑动极光-B(06681)拉升逾14% 脑机接口产业迎政策催化 公司认知障碍数字疗法产品具先发优势